• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    39.05 Down 1.00(2.50%) Feb 27, 4:00PM EST
    |After Hours : 39.05 Down 0.00 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Prev Close:40.05
    Open:40.00
    Bid:36.51 x 500
    Ask:N/A
    1y Target Est:41.00
    Beta:-1.38
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:38.65 - 40.50
    52wk Range:12.17 - 40.75
    Volume:1,825,819
    Avg Vol (3m):1,235,900
    Market Cap:3.01B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXDown 2.50%3.01B
    ABTDown 0.50%71.33B
    LLYUp 0.20%74.42B
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-1.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback